Were the Aveanna CFO’s AVAH share sales open-market transactions?

Yes. The Form 4 classifies each transaction as an open-market sale of common stock. The sales were executed by the company’s stock plan administrator and reported using weighted average prices for multiple trades within specified ranges.

Tax-driven stock sales by Aveanna (AVAH) CFO total 36,030 shares

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. Chief Financial Officer Matthew Buckhalter reported open-market sales of a total of 36,030 shares of common stock over three days. The sales occurred on February 17, 18, and 19, 2026 at weighted average prices of $7.6451, $7.3829, and $7.2082 per share, respectively.

According to the footnotes, these shares were automatically sold to satisfy the reporting person’s tax obligations arising from shares issued upon vesting of equity awards and were executed as part of aggregate sales by the company’s stock plan administrator. After these transactions, Buckhalter directly owns 529,243 shares of Aveanna common stock.

Insider Trade Summary

Net Seller: 36,030 shares

Net Sell 3 txns

Insider Buckhalter Matthew

Role Chief Financial Officer

Sold 36,030 shs ($266K)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share	13,512	$7.2082	$97K
Sale	Common Stock, par value $0.01 per share	13,167	$7.3829	$97K
Sale	Common Stock, par value $0.01 per share	9,351	$7.6451	$71K

Holdings After Transaction: Common Stock, par value $0.01 per share — 529,243 shares (Direct)

Footnotes (4)

F1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
F2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/19/2026 - 09:15 PM

FAQ

What did Aveanna Healthcare (AVAH) disclose in this Form 4 filing?

Aveanna Healthcare reported that CFO Matthew Buckhalter sold 36,030 shares of common stock in three open-market transactions. The sales were related to tax obligations from vested equity awards and executed through the company’s stock plan administrator.

How many Aveanna (AVAH) shares did the CFO sell and on which dates?

CFO Matthew Buckhalter sold a total of 36,030 Aveanna shares. He sold 9,351 shares on February 17, 13,167 shares on February 18, and 13,512 shares on February 19, 2026, according to the Form 4 filing.

What prices did Aveanna’s CFO receive for the AVAH shares sold?

The reported sales used weighted average prices. On February 17, shares sold at $7.6451; on February 18 at $7.3829; and on February 19 at $7.2082 per share, with underlying trades occurring within stated price ranges.

Why were Aveanna (AVAH) shares sold by the CFO in this Form 4?

The filing states the shares were automatically sold to satisfy Matthew Buckhalter’s tax obligations tied to shares issued upon vesting of equity awards. These were handled as aggregate sales by Aveanna’s stock plan administrator.

How many Aveanna (AVAH) shares does the CFO own after these transactions?

After the reported sales, CFO Matthew Buckhalter directly owns 529,243 shares of Aveanna common stock. This post-transaction balance reflects his remaining equity stake following the 36,030 shares sold for tax-related purposes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buckhalter Matthew

(Last)

(First)

(Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA

30339

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	02/17/2026		S⁽¹⁾		9,351	D	$7.6451⁽²⁾	555,922	D
Common Stock, par value $0.01 per share	02/18/2026		S⁽¹⁾		13,167	D	$7.3829⁽³⁾	542,755	D
Common Stock, par value $0.01 per share	02/19/2026		S⁽¹⁾		13,512	D	$7.2082⁽⁴⁾	529,243	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.

2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR